PCM
Pinz Capital Management Portfolio holdings
AUM
$55.2M
1-Year Return
15.62%
This Quarter Return
+47.26%
1 Year Return
-15.62%
3 Year Return
+200.53%
5 Year Return
–
10 Year Return
–
AUM
$218M
AUM Growth
+$180M
(+472%)
Cap. Flow
+$174M
Cap. Flow
% of AUM
79.86%
Top 10 Holdings %
Top 10 Hldgs %
19.36%
Holding
227
New
105
Increased
2
Reduced
4
Closed
116
Top Buys
| 1 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$6.22M |
| 2 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$5.57M |
| 3 |
T-Mobile US
TMUS
|
$5.41M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
$3.78M |
| 5 |
Fox Factory Holding Corp
FOXF
|
$3.66M |
Top Sells
| 1 |
eHealth
EHTH
|
$2.65M |
| 2 |
Carvana
CVNA
|
$2.45M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$2.44M |
| 4 |
Freshpet
FRPT
|
$2.16M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$1.92M |
Sector Composition
| 1 | Healthcare | 32.7% |
| 2 | Technology | 15.04% |
| 3 | Industrials | 9.87% |
| 4 | Real Estate | 8.86% |
| 5 | Consumer Discretionary | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Avidity Biosciences
RNA
$6.48B
| $1.41M | 0.65% |
+50,000
| New | +$1.41M |
|
77
ADC Therapeutics
ADCT
$398M
| $1.41M | 0.64% |
+30,000
| New | +$1.41M |
|
78
BILL Holdings
BILL
$5.24B
| $1.39M | 0.63% |
+15,350
| New | +$1.39M |
|
|
FMTX
79
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.38M | 0.63% |
+29,700
| New | +$1.38M |
|
|
BWIN
80
Baldwin Insurance Group
BWIN
$2.27B
| $1.38M | 0.63% |
+79,600
| New | +$1.38M |
|
|
VIE
81
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $1.35M | 0.62% |
+31,150
| New | +$1.35M |
|
|
API
82
Agora
API
$310M
| $1.33M | 0.61% |
+30,000
| New | +$1.33M |
|
83
Intellia Therapeutics
NTLA
$1.29B
| $1.3M | 0.6% |
+61,950
| New | +$1.3M |
|
84
Boston Scientific
BSX
$159B
| $1.3M | 0.59% |
+36,900
| New | +$1.3M |
|
85
Replimune Group
REPL
$494M
| $1.28M | 0.59% |
+51,498
| New | +$1.28M |
|
86
Legend Biotech
LEGN
$6.66B
| $1.28M | 0.59% |
+30,000
| New | +$1.28M |
|
87
argenx
ARGX
$45.9B
| $1.26M | 0.58% |
+5,600
| New | +$1.26M |
|
88
Dynatrace
DT
$15.1B
| $1.21M | 0.56% |
29,900
-35,200
| -54% | -$1.43M |
|
89
Cannae Holdings
CNNE
$1.09B
| $1.2M | 0.55% |
+29,150
| New | +$1.2M |
|
90
Appian
APPN
$2.26B
| $1.14M | 0.52% |
+22,200
| New | +$1.14M |
|
91
Fiverr
FVRR
$875M
| $1.11M | 0.51% |
+15,000
| New | +$1.11M |
|
92
Gossamer Bio
GOSS
$668M
| $1.1M | 0.5% |
+84,300
| New | +$1.1M |
|
93
RenaissanceRe
RNR
$11.3B
| $1.08M | 0.49% |
+6,300
| New | +$1.08M |
|
94
Iovance Biotherapeutics
IOVA
$901M
| $1.08M | 0.49% |
+39,200
| New | +$1.08M |
|
95
Vroom, Inc. Common Stock
VRM
$140M
| $1.04M | 0.48% |
+250
| New | +$1.04M |
|
96
Reinsurance Group of America
RGA
$12.8B
| $977K | 0.45% |
+12,450
| New | +$977K |
|
|
NARI
97
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $969K | 0.44% |
+20,000
| New | +$969K |
|
98
Repare Therapeutics
RPTX
$72.6M
| $924K | 0.42% |
+29,800
| New | +$924K |
|
|
AKUS
99
DELISTED
Akouos, Inc. Common Stock
AKUS
| $905K | 0.41% |
+40,200
| New | +$905K |
|
100
BioCryst Pharmaceuticals
BCRX
$1.74B
| $866K | 0.4% |
+181,800
| New | +$866K |
|